NCT04969146

Brief Summary

The purpose of the study is to design and test a dyadic sleep intervention for patients diagnosed with cancer and their intimate partner.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 5, 2016

Completed
4.6 years until next milestone

First Submitted

Initial submission to the registry

July 16, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 20, 2021

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 4, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 4, 2026

Completed
Last Updated

April 9, 2026

Status Verified

April 1, 2026

Enrollment Period

9.3 years

First QC Date

July 16, 2021

Last Update Submit

April 4, 2026

Conditions

Keywords

Sleep QualityDepressionQuality of LifeDyadic Function

Outcome Measures

Primary Outcomes (2)

  • Insomnia Severity Index

    Insomnia Reduction by 50% -Total Score (0-28, where 28 is most severe)

    Change from baseline in insomnia reduction at 6 months

  • Insomnia Severity Index

    Insomnia Reduction by 50% -Total Score (0-28, where 28 is most severe)

    Change from baseline in insomnia reduction at 12 months

Secondary Outcomes (4)

  • Pittsburgh Sleep Quality Index (PSQI)

    Change from baseline in improved sleep latency at 6 months.

  • Pittsburgh Sleep Quality Index (PSQI)

    Change from baseline in improved sleep latency at 12 months

  • Patient-reported Outcomes Measurement Information System (PROMIS-29)

    Change from baseline in improved quality of life at 6 months

  • Patient-reported Outcomes Measurement Information System (PROMIS-29)

    Change from baseline in improved quality of life at 12 months

Other Outcomes (2)

  • Patient-reported Outcomes Measurement Information System (PROMIS-29)

    Change from baseline in depressive symptoms at 6 months

  • Patient-reported Outcomes Measurement Information System (PROMIS-29)

    Change from baseline in depressive symptoms at 12 months

Study Arms (2)

Modified Cognitive Behavioral Therapy Intervention Dyadic

EXPERIMENTAL

The patient and caregiver in the dyadic intervention will have 5 sessions of Modified CBTi. The patient and caregiver will complete the assessment at 3- and 6 months follow up.

Behavioral: Dyadic Intervention

Modified Cognitive Behavioral Therapy Intervention Patient Only

EXPERIMENTAL

The patient in the patient only intervention arm will receive 5 sessions of Modified CBTi. The patient and caregiver will complete the assessment at 3- and 6 months follow up

Behavioral: Patient Only Intervention

Interventions

The patient and caregiver dyads will complete and return baseline questionnaires and then be randomized to Modified CBTi Dyadic Intervention. The patient and caregiver in the dyadic intervention will have 5 sessions of Modified CBTi. Upon completion of the intervention, the patient and caregiver will complete the follow up assessments at approximately 3 months and 6 months after the baseline questionnaires.

Modified Cognitive Behavioral Therapy Intervention Dyadic

The patient and caregiver dyads will complete and return baseline questionnaires and then be randomized to Modified CBTi Patient Only Intervention. The patient in the Patient Only Intervention will have 5 sessions of Modified CBTi. Upon completion of the intervention, the patient and caregiver will complete the follow up assessments at approximately 3 months and 6 months after the baseline questionnaires.

Modified Cognitive Behavioral Therapy Intervention Patient Only

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient
  • Diagnosed with cancer
  • Screens positive for sleep problems (5 or greater score on the PSQI)
  • Shares a bed with the caregiver/intimate partner
  • Patient's caregiver/intimate partner also screens positive for sleep problems (5 or greater score on the PSQI)

You may not qualify if:

  • Patient or Caregiver
  • does not screen positive for sleep problems
  • has been diagnosed with sleep apnea or use a continuous positive airway pressure (CPAP) machine
  • has been diagnosed with narcolepsy or restless legs
  • works in a job that requires shift changes
  • does not speak/read English
  • does not share a bed with intimate partner

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh Medical Center Montefiore Liver Cancer Center

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersDepression

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Jennifer L Steel, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Research Coordinators will be masked
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are assigned to one of two groups receiving different interventions in parallel for the duration of the study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 16, 2021

First Posted

July 20, 2021

Study Start

December 5, 2016

Primary Completion

April 4, 2026

Study Completion

April 4, 2026

Last Updated

April 9, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

De-Identified Data may be shared with investigators who request data from the Primary Investigator

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Data will be available at the end of the study for up to one year.
Access Criteria
Appropriate investigator credentials (MD, PhD) and request, and for up to one year after study completion

Locations